发明名称 |
MONOAMINE REUPTAKE INHIBITORS FOR TREATMENT OF CNS DISORDERS |
摘要 |
<p>The present invention relates to compounds that are useful exhibit activity as serotonin, norepinephrine and dopamine reuptake inhibitors, and their pharmaceutically acceptable salts, and their use in the treatment of central nervous system and other disorders.</p> |
申请公布号 |
SK11892001(A3) |
申请公布日期 |
2002.04.04 |
申请号 |
SK20010001189 |
申请日期 |
2000.02.02 |
申请人 |
PFIZER PRODUCTS INC. |
发明人 |
ELLIOTT MARK LEONARD;HOWARD HARRY RALPH JR.;SCHMIDT CHRISTOPHER JOSEPH;SEEGER THOMAS FRANCIS |
分类号 |
A61K31/135;A61P25/24;A61P25/28;C07C217/58;C07C217/90;C07C233/18;C07C235/34;C07C255/37;C07C255/59;C07C311/29;C07C317/32;C07C323/20;C07D207/08;C07D211/22;C07D265/30;C07D279/12;C07D295/096;(IPC1-7):C07C217/58 |
主分类号 |
A61K31/135 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|